What is Cagrilintide?
A long-acting amylin-receptor agonist peptide studied alongside incretin ligands in metabolic research programs.
Research use only. Not for human or veterinary use.
Cagrilintide
5 MG
Overview
Cagrilintide is an acylated amylin analog designed for extended pharmacokinetics in published studies. Papers describe amylin and calcitonin receptor activity and combination work with GLP-1 receptor agonists. Vybe lists the peptide as a research reagent with lot testing, not as a combination therapy kit.
Research areas
Framed as published laboratory and clinical literature. Not treatment guidance.
Amylin receptor pharmacology
In-vitro assays measure potency at AMY and CT receptors and compare half-life extension strategies such as fatty-acid acylation.
Combination metabolic studies
Clinical-stage papers evaluate cagrilintide with GLP-1 agonists under medical protocols. Those protocols are not instructions for research vials.
Published research
Cagrilintide plus semaglutide for the treatment of obesity
The Lancet · 2021
PMID 33894838 · DOI 10.1016/S0140-6736(21)00844-0
Open source
Storage & handling
Lyophilized powder. Store at −20 °C, desiccated and protected from light. Ships at ambient temperature; transfer to −20 °C on receipt.
Frequently asked questions
What is cagrilintide?
A long-acting amylin analog used in published metabolic research. Laboratory use only.
Is this sold for human use?
No. Not for human or veterinary use.
Key facts
- Full name
- Cagrilintide (long-acting amylin analog)
- Common name
- Cagrilintide
- CAS number
- 1415456-99-3
- Molecular formula
- C207H327N51O67S2
- Molecular weight
- 4613.18
- Research category
- Metabolic
- Form
- Lyophilized powder
- Storage
- Lyophilized powder. Store at −20 °C, desiccated and protected from light. Ships at ambient temperature; transfer to −20 °C on receipt.
- Available sizes
- 5mg